The transglutaminase 2 gene (TGM2), a potential molecular marker for chemotherapeutic drug sensitivity, is epigenetically silenced in breast cancer (Q38294813)

From Wikidata

Jump to navigation Jump to search

scientific article published on 03 January 2008

Language	Label	Description	Also known as
English	The transglutaminase 2 gene (TGM2), a potential molecular marker for chemotherapeutic drug sensitivity, is epigenetically silenced in breast cancer	scientific article published on 03 January 2008

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

The transglutaminase 2 gene (TGM2), a potential molecular marker for chemotherapeutic drug sensitivity, is epigenetically silenced in breast cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Lingbao Ai

1

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

Wan-Ju Kim

2

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

Berna Demircan

3

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

Lisa M Dyer

4

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

Kevin J Bray

5

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

Ryan R Skehan

6

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

Nicole A Massoll

7

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

Kevin D Brown

8

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

language of work or name

0 references

publication date

3 January 2008

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

510-518

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

Methylation-induced repression--belts, braces, and chromatin

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM280

21 January 2018

Chromatin remodeling: why it is important in cancer

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM280

21 January 2018

DNA methylation and human disease

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM280

21 January 2018

Tissue transglutaminase: an enzyme with a split personality

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM280

21 January 2018

Protein crosslinking in assembly and remodelling of extracellular matrices: the role of transglutaminases

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM280

21 January 2018

The role of tissue transglutaminase in cell-matrix interactions

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM280

21 January 2018

Tissue transglutaminase (TG2)--a wound response enzyme.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM280

21 January 2018

Tissue transglutaminase is a multifunctional BH3-only protein

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM280

21 January 2018

Tissue transglutaminase protects against apoptosis by modifying the tumor suppressor protein p110 Rb.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM280

21 January 2018

Intracellular localization and activity state of tissue transglutaminase differentially impacts cell death

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM280

21 January 2018

Tissue transglutaminase serves as an inhibitor of apoptosis by cross-linking caspase 3 in thapsigargin-treated cells

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM280

21 January 2018

High levels of transglutaminase expression in doxorubicin-resistant human breast carcinoma cells

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM280

21 January 2018

Regulation of the expression of the tissue transglutaminase gene by DNA methylation

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM280

21 January 2018

Epigenetic silencing of the tumor suppressor cystatin M occurs during breast cancer progression.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM280

21 January 2018

Aberrant methylation of the ATM promoter correlates with increased radiosensitivity in a human colorectal tumor cell line

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM280

21 January 2018

Methylator-induced, mismatch repair-dependent G2 arrest is activated through Chk1 and Chk2

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM280

21 January 2018

The ATM gene is a target for epigenetic silencing in locally advanced breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM280

21 January 2018

The monofunctional alkylating agent N-methyl-N'-nitro-N-nitrosoguanidine triggers apoptosis through p53-dependent and -independent pathways.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM280

21 January 2018

Implications of increased tissue transglutaminase (TG2) expression in drug-resistant breast cancer (MCF-7) cells

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM280

21 January 2018

Reversal of drug resistance in breast cancer cells by transglutaminase 2 inhibition and nuclear factor-kappaB inactivation

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM280

21 January 2018

The human tissue transglutaminase gene maps on chromosome 20q12 by in situ fluorescence hybridization

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM280

21 January 2018

CpG islands in vertebrate genomes

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM280

21 January 2018

Predicting aberrant CpG island methylation

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM280

21 January 2018

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM280

21 January 2018

A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM280

21 January 2018

GPR56, an atypical G protein-coupled receptor, binds tissue transglutaminase, TG2, and inhibits melanoma tumor growth and metastasis

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM280

21 January 2018

Dysregulation of apoptosis in cancer

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM280

21 January 2018

Life in the balance: how BH3-only proteins induce apoptosis.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM280

21 January 2018

Transglutaminase 2 in the balance of cell death and survival

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM280

21 January 2018

Regulation of cell surface tissue transglutaminase: effects on matrix storage of latent transforming growth factor-beta binding protein-1.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM280

21 January 2018

Transforming growth factor-beta in cancer and metastasis

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM280

21 January 2018

Tissue cells feel and respond to the stiffness of their substrate

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM280

21 January 2018

Cell tension, matrix mechanics, and cancer development

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM280

21 January 2018

Implications of tissue transglutaminase expression in malignant melanoma

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM280

21 January 2018

Overexpression of tissue transglutaminase leads to constitutive activation of nuclear factor-kappaB in cancer cells: delineation of a novel pathway

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM280

21 January 2018

Doxorubicin and paclitaxel in the treatment of advanced breast cancer: efficacy and cardiac considerations

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM280

21 January 2018

Identifiers

10.1093/CARCIN/BGM280

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38294813&oldid=1966945401"